PubMed:32394693 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":18,"end":23},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":18,"end":23},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma7088"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":166,"end":174},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":18,"end":23},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T2","span":{"begin":18,"end":23},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T3","span":{"begin":18,"end":23},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T4","span":{"begin":18,"end":23},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":88,"end":97},"obj":"Chemical"},{"id":"T2","span":{"begin":102,"end":125},"obj":"Chemical"},{"id":"T3","span":{"begin":120,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_35472"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":24,"end":30},"obj":"http://purl.obolibrary.org/obo/GO_0048511"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":175},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2","span":{"begin":152,"end":160},"obj":"Species"}],"attributes":[{"id":"A2","pred":"tao:has_database_id","subj":"2","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":126,"end":148},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0001657"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":18,"end":23},"obj":"UBERON:0000948"},{"id":"T2","span":{"begin":53,"end":60},"obj":"UBERON:0000948"},{"id":"T3","span":{"begin":88,"end":97},"obj":"CHEBI:33282;CHEBI:33282"},{"id":"T4","span":{"begin":102,"end":125},"obj":"CHEBI:35472;CHEBI:35472"},{"id":"T5","span":{"begin":166,"end":174},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":175},"obj":"Sentence"}],"text":"An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19.\n"}